Group leader
Pavel Majer
Contacts
Recent papers
The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath Tumor
Molecular Cancer Therapeutics 19 (2): 397-408 (2020).
Enhanced Oral Bioavailability of 2-(Phosphonomethyl)-pentanedioic Acid (2-PMPA) from its (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl (ODOL)-Based Prodrugs
Molecular Pharmaceutics 16 (10): 4292-4301 (2019).
Investigation of flexibility of neuraminidase 150-loop using tamiflu derivatives in influenza A viruses H1N1 and H5N1
Bioorganic and Medicinal Chemistry 27 (13): 2935-2947 (2019).
The unraveling of substrate specificity of histone deacetylase 6 domains using acetylome peptide microarrays and peptide libraries
FASEB Journal 33 (3): 4035-4045 (2019).